0 First chlamydia vaccine to reach Phase I trial appears safe and immunogenic
The first chlamydia vaccine to reach Phase I clinical trials has been observed to be safe and immunogenic in 35 women.
Browsing: Clinical > Vaccines
0 C. difficile exposure in infancy may lead to natural immunization in children
In a study of healthy infants, researchers discover exposure to C. difficile in infancy may provide natural immunization later in childhood.
0 Respiratory syncytial virus: experimental structure-based vaccine candidate shows promise in Phase I trial
Researchers from the University of Texas at Austin have passed an experimental RSV vaccine through Phase I human clinical trial with promising results.
0 US FDA approves RECARBRIO™ for complicated UTIs and complicated intra-abdominal infections: July’s industry headlines
Take a look at this month’s industry headlines including a US FDA approval for RECARBRIO™, positive results for XOFLUZA in children and new ACIP recommendations.
0 MERS vaccine safe and immunogenic in first-in-human trial
A DNA vaccine for MERS-CoV was demonstrated to be well-tolerated and immunogenic in a Phase I, first-in-human trial.
0 20 million children missed out on crucial vaccines in 2018
New research has revealed a dangerous stagnation in the global vaccination rates of children, owing to inequality, conflict and complacency.
0 Funding received for first Phase III trial of a chikungunya vaccine: June’s industry headlines
Take a look at this month’s industry headlines including an FDA approval for Zebraxa, new funding for chikungunya vaccine clinical…
0 Could widespread HPV vaccination eliminate cervical cancer?
A new meta-analysis including data from 60 million individuals over 8 years has demonstrated significant decreases in HPV infections, anogenital wart diagnoses and precancerous cervical lesions following HPV vaccination in girls.
0 Neutralizing antibody shows promise for norovirus vaccine
New study determines a neutralizing antibody which binds to the most pandemic strain of norovirus in humans that could be utilized for an effective vaccine.
0 What influence could genetics have on immunity following vaccination?
A study has revealed genetic variants associated with differing levels of protective antibodies produced after routine immunizations.
